FI54912B - FREQUENCY REQUIREMENT FOR NYA BETA-ARYL-2-AMINOALCOXYSTYROLER - Google Patents

FREQUENCY REQUIREMENT FOR NYA BETA-ARYL-2-AMINOALCOXYSTYROLER

Info

Publication number
FI54912B
FI54912B FI2035/70A FI203570A FI54912B FI 54912 B FI54912 B FI 54912B FI 2035/70 A FI2035/70 A FI 2035/70A FI 203570 A FI203570 A FI 203570A FI 54912 B FI54912 B FI 54912B
Authority
FI
Finland
Prior art keywords
aminoalcoxystyroler
nya
beta
aryl
frequency requirement
Prior art date
Application number
FI2035/70A
Other languages
Finnish (fi)
Other versions
FI54912C (en
Inventor
Erich Mueller
Roland Maier
Willi Diederen
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Application granted granted Critical
Publication of FI54912B publication Critical patent/FI54912B/en
Publication of FI54912C publication Critical patent/FI54912C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C37/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/18—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring monocyclic with unsaturation outside the aromatic ring
    • C07C39/19—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring monocyclic with unsaturation outside the aromatic ring containing carbon-to-carbon double bonds but no carbon-to-carbon triple bonds
    • C07C39/20—Hydroxy-styrenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/12—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40—Radicals substituted by oxygen atoms
    • C07D307/42—Singly bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/16—Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4056—Esters of arylalkanephosphonic acids
FI2035/70A 1969-08-05 1970-07-21 FREQUENCY REQUIREMENT FOR NYA BETA-ARYL-2-AMINOALCOXYSTYROLER FI54912C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1939809A DE1939809B2 (en) 1969-08-05 1969-08-05 β-Aryl-2-aminoalkoxy-styrenes and process for their preparation

Publications (2)

Publication Number Publication Date
FI54912B true FI54912B (en) 1978-12-29
FI54912C FI54912C (en) 1979-04-10

Family

ID=5741970

Family Applications (1)

Application Number Title Priority Date Filing Date
FI2035/70A FI54912C (en) 1969-08-05 1970-07-21 FREQUENCY REQUIREMENT FOR NYA BETA-ARYL-2-AMINOALCOXYSTYROLER

Country Status (25)

Country Link
JP (6) JPS4941433B1 (en)
KR (1) KR780000113B1 (en)
AT (5) AT301565B (en)
BE (1) BE754405A (en)
BG (6) BG17952A3 (en)
CH (6) CH548368A (en)
CS (6) CS170538B2 (en)
DE (1) DE1939809B2 (en)
DK (1) DK139717B (en)
ES (6) ES382427A1 (en)
FI (1) FI54912C (en)
FR (1) FR2068463B1 (en)
GB (1) GB1307436A (en)
HU (1) HU163185B (en)
IE (1) IE34634B1 (en)
IL (1) IL35047A (en)
NL (1) NL7011590A (en)
NO (1) NO135243C (en)
PH (1) PH9520A (en)
PL (2) PL78370B1 (en)
RO (5) RO57794A (en)
SE (1) SE382211B (en)
SU (5) SU450398A3 (en)
YU (2) YU198170A (en)
ZA (1) ZA705411B (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS50139537A (en) * 1974-04-25 1975-11-07
US4220603A (en) * 1977-10-07 1980-09-02 Mitsubishi Chemical Industries, Limited Pharmaceutically active (omega-aminoalkoxy)bibenzyls
JPS6045632B2 (en) * 1978-03-09 1985-10-11 三菱化学株式会社 ω-aminoalkoxystilbenes and their acid addition salts
DE2818765A1 (en) 1978-04-28 1979-11-08 Basf Ag AMINO DERIVATIVES OF 2-METHYL-5- (2-HYDROXYSTYRENE) -1,3,4-THIADIAZOLE
DE2818999A1 (en) * 1978-04-29 1979-11-15 Basf Ag AMINO DERIVATIVES OF 3-ALKYL-5- (2-HYDROXYSTYRYL) -ISOXAZOLES
DE2818998A1 (en) * 1978-04-29 1979-11-15 Basf Ag 3-ALKYL-5- (2-HYDROXY-STYRYL) -ISOXAZOLES AND METHOD FOR THE PRODUCTION THEREOF
JPS5629548A (en) * 1979-08-16 1981-03-24 Mitsubishi Chem Ind Ltd Omega-aminoalkoxystilbenes and their acid addition salts
DE2943405A1 (en) * 1979-10-26 1981-05-07 Basf Ag, 6700 Ludwigshafen NEW AMINO DERIVATIVES OF 5- (2-HYDROXYSTYRYL) -ISOXAZOLE
DE2943406A1 (en) 1979-10-26 1981-05-07 Basf Ag, 6700 Ludwigshafen AMINO DERIVATIVES OF 2-METHYL-5- (2-HYDROXYSTYRYL) -1,3,4-THIADIAZOL
DE3006809A1 (en) * 1980-02-23 1981-09-24 Basf Ag, 6700 Ludwigshafen 2 - ((3-AMINO-2-HYDROXY-PROPOXY) -STYRYL) -ISOXAZOLES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM
JPS5874379U (en) * 1981-11-16 1983-05-19 富士通株式会社 electronic equipment
NZ213986A (en) * 1984-10-30 1989-07-27 Usv Pharma Corp Heterocyclic or aromatic compounds, and pharmaceutical compositions containing such
SG195105A1 (en) 2011-06-10 2013-12-30 Procter & Gamble Absorbent core for disposable absorbent articles
CA2838951C (en) 2011-06-10 2019-07-16 The Procter & Gamble Company An absorbent core for disposable diapers comprising longitudinal channels
ES2751141T3 (en) 2011-06-10 2020-03-30 Procter & Gamble Absorbent structure for absorbent articles
EP2740449B1 (en) 2012-12-10 2019-01-23 The Procter & Gamble Company Absorbent article with high absorbent material content
ES2655690T3 (en) 2013-06-14 2018-02-21 The Procter & Gamble Company Absorbent article and absorbent core formation channels when wet
US9987176B2 (en) 2013-08-27 2018-06-05 The Procter & Gamble Company Absorbent articles with channels
EP2851048B1 (en) 2013-09-19 2018-09-05 The Procter and Gamble Company Absorbent cores having material free areas
ES2606320T3 (en) 2013-12-19 2017-03-23 The Procter & Gamble Company Absorbent cores that have channel-forming areas and wrapping joints in c

Also Published As

Publication number Publication date
IE34634B1 (en) 1975-07-09
PL93130B1 (en) 1977-05-30
CH548981A (en) 1974-05-15
CH548982A (en) 1974-05-15
RO58861A2 (en) 1975-06-30
AT302345B (en) 1972-10-10
ES382425A1 (en) 1972-11-16
SU428597A3 (en) 1974-05-15
AT302346B (en) 1972-10-10
HU163185B (en) 1973-06-28
AT303055B (en) 1972-11-10
BG17950A3 (en) 1974-03-05
ES382429A1 (en) 1972-11-16
KR780000113B1 (en) 1978-04-15
ES382430A1 (en) 1972-12-01
JPS5113147B1 (en) 1976-04-26
SU439965A3 (en) 1974-08-15
RO58837A (en) 1975-09-15
GB1307436A (en) 1973-02-21
IE34634L (en) 1971-02-05
BG20095A3 (en) 1975-10-30
SU439966A3 (en) 1974-08-15
DE1939809A1 (en) 1971-02-18
FR2068463B1 (en) 1974-08-30
ZA705411B (en) 1971-05-27
DE1939809B2 (en) 1978-04-13
PH9520A (en) 1976-01-09
BG17952A3 (en) 1974-03-05
JPS5113150B1 (en) 1976-04-26
CS170534B2 (en) 1976-08-27
CS170533B2 (en) 1976-08-27
FR2068463A1 (en) 1971-08-27
BG17951A3 (en) 1974-03-05
NL7011590A (en) 1971-02-09
ES382426A1 (en) 1972-11-16
SU450398A3 (en) 1974-11-15
CS170536B2 (en) 1976-08-27
CS170538B2 (en) 1976-08-27
JPS5113146B1 (en) 1976-04-26
AT301565B (en) 1972-09-11
SU432712A3 (en) 1974-06-15
RO57548A (en) 1975-02-15
DK139717B (en) 1979-04-02
NO135243B (en) 1976-11-29
RO57794A (en) 1975-06-15
IL35047A (en) 1973-05-31
SE382211B (en) 1976-01-19
FI54912C (en) 1979-04-10
CH548983A (en) 1974-05-15
BG18599A3 (en) 1975-02-25
ES382428A1 (en) 1972-11-16
DE1939809C3 (en) 1979-01-11
JPS5113148B1 (en) 1976-04-26
IL35047A0 (en) 1970-10-30
YU198170A (en) 1979-07-10
CH548367A (en) 1974-04-30
DK139717C (en) 1979-09-17
JPS4941433B1 (en) 1974-11-08
YU37478A (en) 1979-07-10
BE754405A (en) 1971-02-04
AT302344B (en) 1972-10-10
PL78370B1 (en) 1975-06-30
CH548366A (en) 1974-04-30
BG18600A3 (en) 1975-02-25
RO57793A (en) 1975-03-15
CS170537B2 (en) 1976-08-27
JPS5113149B1 (en) 1976-04-26
CH548368A (en) 1974-04-30
NO135243C (en) 1977-03-09
CS170535B2 (en) 1976-08-27
ES382427A1 (en) 1972-11-16

Similar Documents

Publication Publication Date Title
FI54912C (en) FREQUENCY REQUIREMENT FOR NYA BETA-ARYL-2-AMINOALCOXYSTYROLER
FI53673C (en) FOERFARANDE FOER FRAMSTAELLNING AV KOMPOUNDSTYCKEN
SE390736B (en) PROCEDURE FOR MAKING MALTOS
FI53810C (en) FOERFARANDE FOER AVFAERGNING AV AVLOPPSVAETSKA FRAON CELLULOSABLEKNING
FI54593B (en) NYA CEMENTBLANDNINGAR
FI53456C (en) FOERFARANDE FOER FRAMSTAELLNING AV NYA TERAPEUTISKT AKTIVA ISOINDOLINDERIVAT
FI53897B (en) FRAMEWORK FOR THE FRAMEWORK OF THE FRAMEWORK
SE415758B (en) PROCEDURE FOR PREPARING NEW SUBSTITUTED N-AMINOALCYLARYLAMINO-IMIDAZOLINES- (2)
FI53573C (en) FREQUENCY REQUIREMENT FOR KINOXALIN-DI-N-OXIDER
FI55029B (en) FOERFARANDE FOER FRAMSTAELLNING AV NYA TERAPEUTISKT AKTIVA ISOINDOLINDERIVAT
FI53669C (en) SKAERHUVUD FOER PROFILSPAONSKAERNING AV RUNDVIRKE
FI53941B (en) ANORDNING FOER RESNING AV KARTONGER
FI53814B (en) ALFA-AMINOXYCARBONYL HYDROXAMSYRA DERIVATIVES
FI55198B (en) FOERFARANDE FOER FRAMSTAELLNING AV NYA TERAPEUTISKT AKTIVA ISOINDOLINDERIVAT
FI54038B (en) ANORDINATION FOER BESKIKTNING AV EN FIBERSLANG
SE383631B (en) PROCEDURE FOR MAKING NEW 1-PHENOXY-2-HYDROXIDE-3-HYDROXIALKYLAMINOPROPANES
FI46520B (en) FOERFARANDE FOER ATTENUERING AV KALVDIARRE-VIRUS
FI53453C (en) FOERFARANDE FOER FRAMSTAELLNING AV CYTOSTATISKT VERKSAMMA NYA SYCLOALIFATISKA DIFUNKTIONELLA KVAEVEHALTIGA SULFONSYRAESTRAR
FI56008B (en) FOERFARANDE FOER FRAMSTAELLNING AV NYA TERAPEUTISKT VERKSAMMA EN O-SULFOBENZOESYRAIMIDGRUPP INNEHAOLLANDE PIPERIDONER
FI53467C (en) FOERFARANDE FOER FRAMSTAELLNING AV BUNDNA FIBERSKIVOR
FI53305C (en) FRAMEWORK FOR FRAMSTAELLNING AV NYA HEPTA- OCH OCTAPEPTIDER
FI54480C (en) FOERFARANDE FOER FRAMSTAELLNING AV NYA BLODTRYCKSSAENKANDE SUBSTITUERADE 3-AMINO-4-HALOGEN-SYDNON-IMINER
FI54117C (en) FOERFARANDE FOER FRAMSTAELLNING AV NYA KORONARDILATATORISKT VERKANDE SUBSTITUERADE 7-UREIDOCUMARINDERIVAT
FI53816C (en) FOERFARANDE FOER FRAMSTAELLNING AV NYA N N -DIACYLHYDRAZINDERIVAT FOER FOERHINDRANDE AV TUBERKULOS
FI54002C (en) FOERFARANDE FOER FRAMSTAELLNING AV BESTRUKET PAPPER